It’s #FoodAllergy Awareness Week. Over 33M Americans face life-threatening food allergies. Limited treatments leave many at risk. Join us in the fight for better solutions through research, education, and advocacy: bit.ly/4l2tdIh

This #PatientExperienceWeek, we celebrate more than care, we celebrate collaboration. Patient insights and lived experiences are essential to shaping clinical trials that are truly inclusive, accessible and meaningful.

When we listen, we learn and do better for everyone.

#PtExp #PxWeek

Unlike broad immunosuppressants, LYTACs are designed to specifically and rapidly eliminate disease-causing autoantibodies. Could this be the future of autoimmune therapy?

Learn more here: lyciatx.com

hashtag#ProteinDegradation hashtag#Biotech

At Lycia, we’re pioneering a new approach to treating previously undruggable diseases. If you’re passionate about pushing the boundaries of science, we’re hiring!

Check out our job openings: jobs.lever.co/LyciaTherape...

#LifeAtLycia #BiotechCareers

We stood up for science! On Friday, our team joined the #StandUpForScience2025 Rally to support research & innovation. Amazing energy, inspiring voices—let’s keep advocating for science!

#ScienceMatters #ResearchForAll #StandUpForScience

Science fuels progress, drives innovation, and improves lives.

We’re proud to stand up for research and evidence-based decision-making at the #StandUpForScience2025 Rally —where Lycia’s founder, Nobel Laureate @carolynbertozzi.bskyverified.social will be a featured speaker.

Join us!

Thank you to the industry leaders, researchers, and clinicians who connected with us at AAAAI/WAO in San Diego! It was inspiring to discuss the future of allergy and immunology and share how Lycia’s LYTAC platform is advancing targeted protein degradation. Excited to continue the conversation!

Lycia Therapeutics’ leadership will attend the 2025 AAAAI/WAO Joint Congress in San Diego, Feb 28 – Mar 3.

We’re excited to discuss the latest in allergy & immunology R&D and share how our LYTAC platform is shaping the future of targeted protein degradation. Let’s connect at #AAAAI2025!

Please join us in welcoming Chin Lee, MD, MPH, as Lycia’s Chief Medical Officer to help advance our pipeline of LYTAC-based therapies for autoimmune diseases.

Welcome, Dr. Lee! www.globenewswire.com/news-release...

Last week, we partnered with Biocom’s Generation #STEAM to inspire the next generation! We hosted Tennyson HS students for lab tours, career panels, and hands-on activities.

Our team also assembled 209 STEAM kits for Martin Elementary and BioLink Depot. Proud to give back!